Shinya Yamanaka, a Japanese Nobel Prize-winner, speaks during an interview conducted by the Yomiuri Shimbun in Kyoto City, Kyoto Prefecture on May 4, 2018. Nakayama is a director of Center for iPS
Nobel laureate Yamanaka allies with Takeda in hunt for blockbuster drugs | The Japan Times
Landmark surgery a step forward for iPS, says Nobel laureate - Nikkei Asia
Shinya Yamanaka Wins 2012 Nobel Prize in Medicine | UC San Francisco
Shinya Yamanaka – Facts - NobelPrize.org
Cloning and stem cell Nobel for Gurdon and Yamanaka | New Scientist
There must be another way'- thought iPS cell guru Shinya Yamanaka
Shinya Yamanaka - Nobel Lecture: The Winding Road to Pluripotency
Advice on Studying Abroad: Stem Cell Researcher Shinya Yamanaka « American View
Nobel prize in physiology or medicine 2012: as it happened | Science | The Guardian
Nobel laureate Yamanaka to retire as director of iPS cell center | The Asahi Shimbun: Breaking News, Japan News and Analysis
Nobel Prize Doctor Yamanaka: Stem Cell Progress 'Just the Beginning' | JAPAN Forward
Nobel Prize goes to stem cell pioneers John B. Gurdon and Shinya Yamanaka | Eurostemcell
Nobel Prize in medicine awarded to Sir John Gurdon and Shinya Yamanaka | CNN
Reprogrammed frog and mouse cells win the 2012 Nobel Prize – Speaking of Research
iPS Cells Accelerate Medical Progress / The Government of Japan - JapanGov -
File:Lecture by Nobel Laureate Dr. Shinya Yamanaka “New Era of Medicine with iPS Cells- Message to Future Scientists“ (46596989145).jpg - Wikimedia Commons
Japanese stem cell researcher wins 2012 Nobel in medicine
Shinya Yamanaka, a Japanese Nobel Prize-winner, speaks during an interview conducted by the Yomiuri Shimbun in Kyoto City, Kyoto Prefecture on March 17, 2020. Nakayama is a director of Center for iPS
File:Lecture by Nobel Laureate Dr. Shinya Yamanaka “New Era of Medicine with iPS Cells- Message to Future Scientists“ (46596989035).jpg - Wikimedia Commons
Nobel laureate Yamanaka plans to fully commit to iPS cells work | The Asahi Shimbun: Breaking News, Japan News and Analysis